FMR CORP 13D and 13G filings for Vor Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:34 am Sale |
2024-12-31 | 13G | Vor Biopharma Inc. VOR |
FMR CORP | 6,419,633 9.300% |
-1,199,315 (-15.74%) |
Filing |
| 2024-02-09 10:05 am Sale |
2024-02-08 | 13G | Vor Biopharma Inc. VOR |
FMR CORP | 7,618,948 11.236% |
-351,563 (-4.41%) |
Filing |
| 2023-01-10 12:48 pm Purchase |
2023-01-09 | 13G | Vor Biopharma Inc. VOR |
FMR CORP | 7,970,511 12.141% |
4,789,048 (+150.53%) |
Filing |
| 2022-02-09 10:01 am Sale |
2022-02-08 | 13G | Vor Biopharma Inc. VOR |
FMR CORP | 3,181,463 8.531% |
-753,775 (-19.15%) |
Filing |
| 2021-03-10 09:46 am Purchase |
2021-03-09 | 13G | Vor Biopharma Inc. VOR |
FMR CORP | 3,935,238 10.601% |
3,935,238 (New Position) |
Filing |